Insider · CIK 0001181154
DAVENPORT FRED B JR
Reports to the SEC for 2 companies · CINCINNATI, OH
Transactions
50
Companies
2
Filings
10
CIK
0001181154
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-08-19 | MEDPMedpace Holdings, Inc.M Exercise/Conversion | +$255K |
| 2026-08-19 | MEDPMedpace Holdings, Inc.M Exercise/Conversion | +$325K |
| 2026-08-19 | MEDPMedpace Holdings, Inc.M Exercise/Conversion | +$300K |
| 2026-08-19 | MEDPMedpace Holdings, Inc.S Sale | −$4.41M |
| 2026-08-19 | MEDPMedpace Holdings, Inc. · Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2026-08-19 | MEDPMedpace Holdings, Inc. · Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2026-08-19 | MEDPMedpace Holdings, Inc. · Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2026-05-15 | MEDPMedpace Holdings, Inc. · Stock Option (Right to Buy)A Award | — |
| 2025-10-30 | MEDPMedpace Holdings, Inc.M Exercise/Conversion | +$356K |
| 2025-10-30 | MEDPMedpace Holdings, Inc.S Sale | −$3.47M |
| 2025-10-30 | MEDPMedpace Holdings, Inc. · Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2025-05-16 | MEDPMedpace Holdings, Inc. · Stock Option (Right to Buy)A Award | — |
| 2025-04-24 | MEDPMedpace Holdings, Inc.M Exercise/Conversion | +$269K |
| 2025-04-24 | MEDPMedpace Holdings, Inc.S Sale | −$517K |
| 2025-04-24 | MEDPMedpace Holdings, Inc. · Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2024-05-17 | MEDPMedpace Holdings, Inc. · Stock Option (Right to Buy)A Award | — |
| 2023-05-19 | MEDPMedpace Holdings, Inc. · Stock Option (Right to Buy)A Award | — |
| 2022-05-20 | MEDPMedpace Holdings, Inc. · Stock Option (Right to Buy)A Award | — |
| 2022-02-17 | MEDPMedpace Holdings, Inc.P Purchase | +$72.9K |
| 2021-05-14 | MEDPMedpace Holdings, Inc. · Stock Option (Right to Buy)A Award | — |
| 2020-05-15 | MEDPMedpace Holdings, Inc. · Stock Option (Right to Buy)A Award | — |
| 2019-05-17 | MEDPMedpace Holdings, Inc. · Stock Option (Right to Buy)A Award | — |
| 2018-08-13 | MEDPMedpace Holdings, Inc. · Stock Option (Right to Buy)A Award | — |
| 2006-02-15 | PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCM Exercise/Conversion | +$131K |
| 2006-02-15 | PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCM Exercise/Conversion | +$753K |
| 2006-02-15 | PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCS Sale | −$166K |
| 2006-02-15 | PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCS Sale | −$66K |
| 2006-02-15 | PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCS Sale | −$166K |
| 2006-02-15 | PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCS Sale | −$99.2K |
| 2006-02-15 | PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCS Sale | −$66.1K |
| 2006-02-15 | PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCS Sale | −$166K |
| 2006-02-15 | PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCS Sale | −$132K |
| 2006-02-15 | PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCS Sale | −$132K |
| 2006-02-15 | PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCS Sale | −$330K |
| 2006-02-15 | PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCS Sale | −$165K |
| 2006-02-15 | PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCS Sale | −$496K |
| 2006-02-15 | PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCStock Options (to buy)M Exercise/Conversion | — |
| 2006-02-15 | PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCStock Options (to buy)M Exercise/Conversion | — |
| 2006-02-14 | PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCM Exercise/Conversion | +$459K |
| 2006-02-14 | PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCS Sale | −$235K |
| 2006-02-14 | PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCS Sale | −$932K |
| 2006-02-14 | PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCStock Options (to buy)M Exercise/Conversion | — |
| 2005-07-21 | PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCM Exercise/Conversion | +$131K |
| 2005-07-21 | PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCS Sale | −$286K |
| 2005-07-21 | PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCS Sale | −$310K |
| 2005-07-21 | PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCS Sale | −$286K |
| 2005-07-21 | PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCS Sale | −$11.9K |
| 2005-07-21 | PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCStock Options (to buy)M Exercise/Conversion | — |
| 2005-07-20 | PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCS Sale | −$298K |
| 2003-12-03 | PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCStock Options (to buy)A Award | — |
Recent filings
- 4DAVENPORT FRED B JR0000892251-26-000123SEC(opens sec.gov)
- 4DAVENPORT FRED B JR0001181154-26-000002SEC(opens sec.gov)
- 4DAVENPORT FRED B JR0001181154-25-000004SEC(opens sec.gov)
- 4DAVENPORT FRED B JR0001668397-25-000065SEC(opens sec.gov)
- 4DAVENPORT FRED B JR0001668397-25-000061SEC(opens sec.gov)
- 4DAVENPORT FRED B JR0001668397-24-000105SEC(opens sec.gov)
- 4DAVENPORT FRED B JR0000892251-23-000059SEC(opens sec.gov)
- 4DAVENPORT FRED B JR0001567619-22-011617SEC(opens sec.gov)
- 4DAVENPORT FRED B JR0001567619-22-005254SEC(opens sec.gov)
- 4DAVENPORT FRED B JR0001567619-21-010623SEC(opens sec.gov)
Companies
Address
C/O MEDPACE HOLDINGS, INC. 5375 MEDPACE WAY
CINCINNATI, OH, 45227